Patients with symptomatic severe aortic stenosis undergoing CoreValve or Evolut TAVI have better 5-year bioprosthetic valve ...

[101] For both of the principal TAVI device companies (Edwards Lifesciences and Medtronic CoreValve), such discussions remain mandatory for provision of a prosthesis for a particular patient from ...

Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction ...

Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial’s two-year ...

The preliminary results look promising for the Evolut for specific patients. The trial consists of mostly women, who have ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Discussions covered identifying eligible patients, increasing the number of specialized centers across Egypt’s governorates, ...

Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic annuli patients.

Medtronic transcatheter aortic valve replacement (TAVR) system recently celebrated a significant milestone: 20 years since its first-in-human procedure in 2004. This landmark achievement underscores ...

Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial’s two-year outcomes of the Evolut transfemoral transcatheter aortic valve ...